Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: A$0.17 M
• Last 3 months FTD volume: A$4.76 M
• Last 12 months FTD volume: A$11 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	A$56.21 M	A$0.12 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	A$4.5 M	A$68.25 M	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	A$3.69 M	A$9.48 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	A$1.5 M	A$12.43 M	🇺🇸 USA
Amicus Therapeutics FOLD	A$8.6 M	A$17.99 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$8.34 M	A$13.64 M	🇺🇸 USA